Susan Hasty, Publisher
Table of Contents . . . October 28th, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in AIDS Weekly and Law | Other Publications
Trinity Biotech plc - Biotech receives U.S. FDA approval for HIV test with finger stick whole blood
HIV/AIDS Treatment - Man claims doctor refused to perform surgery because of HIV
Inst Natl Sante Recherche Med E0109, Paris - CD8+ T cells specific for EBV/CMV/FLU activated during primary HIV infection
Starpharma - Australian company to lead NIH-funded project to prevent HIV, other STDs
U.S. National Institutes of Health - CD25+/CD4+ cells associated with favorable clinical markers of HIV status
AIDS Healthcare Foundation - California governor Schwarzenegger signs HIV/AIDS pharmacy bill
Chinese Academy of Science - Novel anti-HIV drug candidate targets CD4 lymphocytes
FEI - ParaGard offers safe, effective alternative to hormonal birth control
HIV/AIDS Prevention - Barcelona to play World XI in AIDS benefit
HIV/AIDS Prevention - England's Prime Minister and musician work to help Africa
HIV/AIDS Threat - Former President De Klerk says AIDS remains South Africa's biggest threat
HIV/AIDS Treatment - Committee approves needle exchange, treatment funding
Indiana University - Inhibitor design wraps packing defects in HIV-1 proteins
Inst. National Communicable Diseases, Johannesburg - JC virus genotypes 3 and 7 identified in South African patients
Institute Oswaldo Cruz, Rio De Janeiro - Furamidine analog markedly potentiates activity against T. cruzi/L. amazonensis
Johns Hopkins University - Some AIDS drugs promote neurological damage
Kurume University School of Medicine, Fukuoka - LAMPS of M. fermentans/M. penetrans activate HIV LTR through Toll-like receptors
Loma Linda University - HIV cholera toxin fusion gene expressed in transgenic potato
Mary Ann Liebert, Inc. - New book on medication adherence for AIDS patients offers solutions
Merck Research Laboratories - Novel HIV-1 integrase inhibitor has potent antiviral activity
National Jewish Medical Center, Denver - d4T treatment enhances mitochondrial oxidative stress
Slotervaart Hospital, Amsterdam - Race is not associated with pharmacokinetics of nevirapine
The Immune Response Corporation - Drug boosts HIV-1-specific lymphocyte activity in infected patients, study shows
U.S. National Institutes of Health - Pathogenic SHIVs and SIVs target different CD4+ T cell subsets
Univ. Mediterranee, Marseille - HIV-1 and MLV Gag sufficient to recruit APOBEC3G into virus-like particles
University Autonoma of Barcelona, Bellaterra - HIV-1 gp120 decreases NO-dependent cyclic GMP accumulation in brain astroglia
University College, London - New HIV technologies alter the nature of HIV medicine materially and socially
University of Alabama - Mutations alter capsid protein assembly rate without changing monomer stability
University of California San Francisco - Immune activation set point is established early in HIV infection
University of Minnesota - APOBEC3F properties/hypermutation preferences indicate activity against HIV-1
University of Rochester - HIV phenotypic/genotypic markers of resistance evaluated at virologic failure
University of Washington - Drug-resistant HIV mutants higher in PBMC than plasma after changes in ART
VA Medical Center, Houston - Fibronectin fragments stimulate transendothelial migration of HIV-1-infected MNL
Wildlife Trust - Hurricanes and extreme weather causing plant diseases
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.